{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T02:07:58Z","timestamp":1791338878019,"version":"4.3.1"},"reference-count":60,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,7,17]],"date-time":"2025-07-17T00:00:00Z","timestamp":1752710400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,7,17]],"date-time":"2025-07-17T00:00:00Z","timestamp":1752710400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/100000054","name":"U.S. Department of Health & Human Services | NIH | National Cancer Institute","doi-asserted-by":"publisher","award":["R01CA233490"],"award-info":[{"award-number":["R01CA233490"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"U.S. Department of Health & Human Services | NIH | National Cancer Institute","doi-asserted-by":"publisher","award":["U54CA272691"],"award-info":[{"award-number":["U54CA272691"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Blood Cancer J."],"DOI":"10.1038\/s41408-025-01323-8","type":"journal-article","created":{"date-parts":[[2025,7,17]],"date-time":"2025-07-17T18:29:16Z","timestamp":1752776956000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Prognostic gene expression and microRNA profiling signatures and genetic alterations in primary testicular diffuse large B-cell lymphoma"],"prefix":"10.1038","volume":"15","author":[{"given":"Wenyu","family":"Shi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7615-3949","authenticated-orcid":false,"given":"Zijun Y.","family":"Xu-Monette","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9191-5836","authenticated-orcid":false,"given":"Youchao","family":"Jia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1100-3819","authenticated-orcid":false,"given":"Alexandar","family":"Tzankov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heounjeong","family":"Go","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ling","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0055-325X","authenticated-orcid":false,"given":"Maurilio","family":"Ponzoni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yafei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiongli","family":"Zhai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5700-2141","authenticated-orcid":false,"given":"Anamarija M.","family":"Perry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoxiao","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"April","family":"Chiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9513-245X","authenticated-orcid":false,"given":"Mina L.","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlo","family":"Visco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2488-435X","authenticated-orcid":false,"given":"Karen","family":"Dybkaer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9746-9352","authenticated-orcid":false,"given":"Henry","family":"Withers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Long","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-6833-7395","authenticated-orcid":false,"given":"Alyssa F.","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1799-1448","authenticated-orcid":false,"given":"Yi","family":"Miao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Everardo","family":"Macias","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dehong","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen","family":"Shuai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0942-7858","authenticated-orcid":false,"given":"Bangchen","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9931-4055","authenticated-orcid":false,"given":"Jianyong","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6250-048X","authenticated-orcid":false,"given":"Govind","family":"Bhagat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Youli","family":"Zu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zenggang","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-4026-5603","authenticated-orcid":false,"given":"William","family":"Choi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Santiago","family":"Montes-Moreno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5638-4371","authenticated-orcid":false,"given":"Weina","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. Han van","family":"Krieken","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2041-3630","authenticated-orcid":false,"given":"Michael B.","family":"M\u00f8ller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinfang","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin M.","family":"Parsons","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shanxiang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric D.","family":"Hsi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6307-4854","authenticated-orcid":false,"given":"Aliyah R.","family":"Sohani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeremy S.","family":"Abramson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9606-6124","authenticated-orcid":false,"given":"Andr\u00e9s J. M.","family":"Ferreri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7271-4438","authenticated-orcid":false,"given":"Bing","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8838-1714","authenticated-orcid":false,"given":"Yong","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5755-8932","authenticated-orcid":false,"given":"Ken H.","family":"Young","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,7,17]]},"reference":[{"key":"1323_CR1","doi-asserted-by":"publisher","first-page":"1229","DOI":"10.1182\/blood.2022015851","volume":"140","author":"E Campo","year":"2022","unstructured":"Campo E, Jaffe ES, Cook JR, Quintanilla-Martinez L, Swerdlow SH, Anderson KC, et al. The International Consensus Classification of Mature Lymphoid Neoplasms: a report from the Clinical Advisory Committee. Blood. 2022;140:1229\u201353.","journal-title":"Blood"},{"key":"1323_CR2","doi-asserted-by":"publisher","first-page":"4049","DOI":"10.3390\/cancers13164049","volume":"13","author":"M Pollari","year":"2021","unstructured":"Pollari M, Leivonen SK, Lepp\u00e4 S. Testicular diffuse large B-cell lymphoma-clinical, molecular, and immunological features. Cancers. 2021;13:4049.","journal-title":"Cancers"},{"key":"1323_CR3","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1016\/j.blre.2017.12.001","volume":"32","author":"DDW Twa","year":"2018","unstructured":"Twa DDW, Mottok A, Savage KJ, Steidl C. The pathobiology of primary testicular diffuse large B-cell lymphoma: Implications for novel therapies. Blood Rev. 2018;32:249\u201355.","journal-title":"Blood Rev"},{"key":"1323_CR4","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1182\/blood-2013-10-530659","volume":"123","author":"CY Cheah","year":"2014","unstructured":"Cheah CY, Wirth A, Seymour JF. Primary testicular lymphoma. Blood. 2014;123:486\u201393.","journal-title":"Blood"},{"key":"1323_CR5","doi-asserted-by":"publisher","first-page":"1541","DOI":"10.1182\/bloodadvances.2023011251","volume":"8","author":"A Conconi","year":"2024","unstructured":"Conconi A, Chiappella A, Ferreri AJM, Stathis A, Botto B, Sassone M, et al. IELSG30 phase 2 trial: intravenous and intrathecal CNS prophylaxis in primary testicular diffuse large B-cell lymphoma. Blood Adv. 2024;8:1541\u20139.","journal-title":"Blood Adv"},{"key":"1323_CR6","doi-asserted-by":"publisher","first-page":"2766","DOI":"10.1200\/JCO.2010.31.4187","volume":"29","author":"U Vitolo","year":"2011","unstructured":"Vitolo U, Chiappella A, Ferreri AJ, Martelli M, Baldi I, Balzarotti M, et al. First-line treatment for primary testicular diffuse large B-cell lymphoma with rituximab-CHOP, CNS prophylaxis, and contralateral testis irradiation: final results of an international phase II trial. J Clin Oncol. 2011;29:2766\u201372.","journal-title":"J Clin Oncol"},{"key":"1323_CR7","first-page":"675","volume":"104","author":"H Mocikova","year":"2025","unstructured":"Mocikova H, Janikova A, Sykorova A, Prochazka V, Pirnos J, Duras J, et al. Outcome of patients with diffuse large B-cell lymphoma and testicular involvement - real world data. Ann Hematol. 2025;104:675\u201384.","journal-title":"Ann Hematol"},{"key":"1323_CR8","doi-asserted-by":"publisher","first-page":"869","DOI":"10.1182\/blood-2015-10-673236","volume":"127","author":"B Chapuy","year":"2016","unstructured":"Chapuy B, Roemer MG, Stewart C, Tan Y, Abo RP, Zhang L, et al. Targetable genetic features of primary testicular and primary central nervous system lymphomas. Blood. 2016;127:869\u201381.","journal-title":"Blood"},{"key":"1323_CR9","first-page":"1598","volume":"6","author":"I Bonzheim","year":"2022","unstructured":"Bonzheim I, Sander P, Salmer\u00f3n-Villalobos J, S\u00fcsskind D, Szurman P, Gekeler F, et al. The molecular hallmarks of primary and secondary vitreoretinal lymphoma. Blood Adv. 2022;6:1598\u2013607.","journal-title":"Blood Adv"},{"key":"1323_CR10","doi-asserted-by":"publisher","first-page":"2698","DOI":"10.1158\/1078-0432.CCR-05-2617","volume":"12","author":"M Booman","year":"2006","unstructured":"Booman M, Douwes J, Glas AM, Riemersma SA, Jordanova ES, Kok K, et al. Mechanisms and effects of loss of human leukocyte antigen class II expression in immune-privileged site-associated B-cell lymphoma. Clin Cancer Res. 2006;12:2698\u2013705.","journal-title":"Clin Cancer Res"},{"key":"1323_CR11","doi-asserted-by":"publisher","first-page":"3569","DOI":"10.1182\/blood.V96.10.3569","volume":"96","author":"SA Riemersma","year":"2000","unstructured":"Riemersma SA, Jordanova ES, Schop RF, Philippo K, Looijenga LH, Schuuring E, et al. Extensive genetic alterations of the HLA region, including homozygous deletions of HLA class II genes in B-cell lymphomas arising in immune-privileged sites. Blood. 2000;96:3569\u201377.","journal-title":"Blood"},{"key":"1323_CR12","doi-asserted-by":"publisher","first-page":"2285","DOI":"10.3390\/cancers15082285","volume":"15","author":"KS Kurz","year":"2023","unstructured":"Kurz KS, Ott M, Kalmbach S, Steinlein S, Kalla C, Horn H, et al. Large B-cell lymphomas in the 5th Edition of the WHO-Classification of Haematolymphoid Neoplasms-Updated Classification and New Concepts. Cancers. 2023;15:2285.","journal-title":"Cancers"},{"key":"1323_CR13","unstructured":"Coupland SE, Ferry JA, Balchelor T, Hoang-Xuan K, Calaminici M, Jeon YK, et al., Primary large B-cell lymphoma of immune-privileged sites. In: WHO Classification of Tumours Editorial Board. Haematolymphoid tumours. WHO Classification of Tumors Series, 5th ed. Volume 11. Lyon (Lyon, France): International Agency for Research on Cancer 2024. Pages 509-16."},{"key":"1323_CR14","doi-asserted-by":"publisher","first-page":"2593","DOI":"10.1182\/blood.2023020911","volume":"144","author":"M Roschewski","year":"2024","unstructured":"Roschewski M, Phelan JD, Jaffe ES. Primary large B-cell lymphomas of immune-privileged sites. Blood. 2024;144:2593\u2013603.","journal-title":"Blood"},{"key":"1323_CR15","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1038\/s41591-018-0016-8","volume":"24","author":"B Chapuy","year":"2018","unstructured":"Chapuy B, Stewart C, Dunford AJ, Kim J, Kamburov A, Redd RA, et al. Molecular subtypes of diffuse large B cell lymphoma are associated with distinct pathogenic mechanisms and outcomes. Nat Med. 2018;24:679\u201390.","journal-title":"Nat Med"},{"key":"1323_CR16","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1016\/j.ccell.2020.03.015","volume":"37","author":"GW Wright","year":"2020","unstructured":"Wright GW, Huang DW, Phelan JD, Coulibaly ZA, Roulland S, Young RM, et al. A probabilistic classification tool for genetic subtypes of diffuse large B cell lymphoma with therapeutic implications. Cancer Cell. 2020;37:551\u201368 e14.","journal-title":"Cancer Cell"},{"key":"1323_CR17","first-page":"1339","volume":"110","author":"M Autio","year":"2025","unstructured":"Autio M, Br\u00fcck O, Pollari M, Karjalainen-Lindsberg ML, Beiske K, J\u00f8rgensen JM, et al. Characterization of tumor microenvironment and cell interaction patterns in testicular and diffuse large B-cell lymphomas. Haematologica 2025;110:1339\u201350.","journal-title":"Haematologica"},{"key":"1323_CR18","doi-asserted-by":"publisher","first-page":"1917","DOI":"10.1158\/0008-5472.CAN-22-3814","volume":"83","author":"GT Los-de Vries","year":"2023","unstructured":"Los-de Vries GT, Stathi P, Rutkens R, Hijmering NJ, Luijks J, Groenen P, et al. Large B-cell lymphomas of immune-privileged sites relapse via parallel clonal evolution from a common progenitor B cell. Cancer Res. 2023;83:1917\u201327.","journal-title":"Cancer Res"},{"key":"1323_CR19","doi-asserted-by":"publisher","first-page":"2385","DOI":"10.1038\/leu.2016.135","volume":"30","author":"D Juskevicius","year":"2016","unstructured":"Juskevicius D, Lorber T, Gsponer J, Perrina V, Ruiz C, Stenner-Liewen F, et al. Distinct genetic evolution patterns of relapsing diffuse large B-cell lymphoma revealed by genome-wide copy number aberration and targeted sequencing analysis. Leukemia. 2016;30:2385\u201395.","journal-title":"Leukemia"},{"key":"1323_CR20","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1002\/gcc.10234","volume":"38","author":"T Kawakami","year":"2003","unstructured":"Kawakami T, Okamoto K, Kataoka A, Koizumi S, Iwaki H, Sugihara H, et al. Multipoint methylation analysis indicates a distinctive epigenetic phenotype among testicular germ cell tumors and testicular malignant lymphomas. Genes Chromosomes Cancer. 2003;38:97\u2013101.","journal-title":"Genes Chromosomes Cancer"},{"key":"1323_CR21","doi-asserted-by":"publisher","DOI":"10.1186\/s13148-022-01344-1","volume":"14","author":"Y Shen","year":"2022","unstructured":"Shen Y, Ou J, He B, Yang J, Liu H, Wang L, et al. 5-Hydroxymethylation alterations in cell-free DNA reflect molecular distinctions of diffuse large B cell lymphoma at different primary sites. Clin Epigenet. 2022;14:126.","journal-title":"Clin Epigenet"},{"key":"1323_CR22","doi-asserted-by":"publisher","first-page":"225","DOI":"10.7150\/ijms.65517","volume":"19","author":"Y Shen","year":"2022","unstructured":"Shen Y, Wang L, Ou J, Wang B, Cen X. Loss of 5-hydroxymethylcytosine as a poor prognostic factor for primary testicular diffuse Large B-cell lymphoma. Int J Med Sci. 2022;19:225\u201332.","journal-title":"Int J Med Sci"},{"key":"1323_CR23","doi-asserted-by":"publisher","first-page":"828","DOI":"10.1002\/hon.3190","volume":"41","author":"A Mansoor","year":"2023","unstructured":"Mansoor A, Akhter A, Shabani-Rad MT, Deschenes J, Yilmaz A, Trpkov K, et al. Primary testicular lymphoma demonstrates overexpression of the Wilms tumor 1 gene and different mRNA and miRNA expression profiles compared to nodal diffuse large B-cell lymphoma. Hematol Oncol. 2023;41:828\u201337.","journal-title":"Hematol Oncol"},{"key":"1323_CR24","doi-asserted-by":"publisher","first-page":"9489","DOI":"10.2147\/CMAR.S341342","volume":"13","author":"Z Yan","year":"2021","unstructured":"Yan Z, Yao S, Wang Y, Liu Y, Yao Z. Primary testicular lymphoma with central nervous system relapse was successfully treated by a chemo-free regimen: a case report and literature review. Cancer Manag Res. 2021;13:9489\u2013500.","journal-title":"Cancer Manag Res"},{"key":"1323_CR25","doi-asserted-by":"publisher","first-page":"1256","DOI":"10.1182\/blood.2020006338","volume":"137","author":"DDW Twa","year":"2021","unstructured":"Twa DDW, Lee DG, Tan KL, Slack GW, Ben-Neriah S, Villa D, et al. Genomic predictors of central nervous system relapse in primary testicular diffuse large B-cell lymphoma. Blood. 2021;137:1256\u20139.","journal-title":"Blood"},{"key":"1323_CR26","doi-asserted-by":"publisher","DOI":"10.1186\/s40364-020-00189-1","volume":"8","author":"X Wang","year":"2020","unstructured":"Wang X, Xu X, Cai W, Bao H, Huang H, Liu Y, et al. TBL1XR1 mutation predicts poor outcome in primary testicular diffuse large B-cell lymphoma patients. Biomark Res. 2020;8:10.","journal-title":"Biomark Res"},{"key":"1323_CR27","doi-asserted-by":"publisher","first-page":"2831","DOI":"10.1007\/s12253-020-00864-6","volume":"26","author":"S Hatzl","year":"2020","unstructured":"Hatzl S, Posch F, Schulz E, Gornicec M, Deutsch A, Beham-Schmid C, et al. The Role of Immunohistochemical Overexpression of p53 as Adverse Prognostic Factor in Primary Testicular Diffuse Large B Cell Lymphoma. Pathol Oncol Res. 2020;26:2831\u20133.","journal-title":"Pathol Oncol Res"},{"key":"1323_CR28","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1002\/hon.2090","volume":"32","author":"T Menter","year":"2014","unstructured":"Menter T, Ernst M, Drachneris J, Dirnhofer S, Barghorn A, Went P, et al. Phenotype profiling of primary testicular diffuse large B-cell lymphomas. Hematol Oncol. 2014;32:72\u201381.","journal-title":"Hematol Oncol"},{"key":"1323_CR29","doi-asserted-by":"publisher","first-page":"1908","DOI":"10.3324\/haematol.2018.197194","volume":"103","author":"M Pollari","year":"2018","unstructured":"Pollari M, Br\u00fcck O, Pellinen T, V\u00e4h\u00e4murto P, Karjalainen-Lindsberg ML, Mannisto S, et al. PD-L1(+) tumor-associated macrophages and PD-1(+) tumor-infiltrating lymphocytes predict survival in primary testicular lymphoma. Haematologica. 2018;103:1908\u201314.","journal-title":"Haematologica"},{"key":"1323_CR30","doi-asserted-by":"publisher","first-page":"338","DOI":"10.3324\/haematol.2018.200105","volume":"104","author":"SK Leivonen","year":"2019","unstructured":"Leivonen SK, Pollari M, Br\u00fcck O, Pellinen T, Autio M, Karjalainen-Lindsberg ML, et al. T-cell inflamed tumor microenvironment predicts favorable prognosis in primary testicular lymphoma. Haematologica. 2019;104:338\u201346.","journal-title":"Haematologica"},{"key":"1323_CR31","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1038\/leu.2015.237","volume":"30","author":"L Deng","year":"2016","unstructured":"Deng L, Xu-Monette ZY, Loghavi S, Manyam GC, Xia Y, Visco C, et al. Primary testicular diffuse large B-cell lymphoma displays distinct clinical and biological features for treatment failure in rituximab era: a report from the International PTL Consortium. Leukemia. 2016;30:361\u201372.","journal-title":"Leukemia"},{"key":"1323_CR32","doi-asserted-by":"publisher","first-page":"972","DOI":"10.1158\/1078-0432.CCR-21-2949","volume":"28","author":"ZY Xu-Monette","year":"2022","unstructured":"Xu-Monette ZY, Wei L, Fang X, Au Q, Nunns H, Nagy M, et al. Genetic subtyping and phenotypic characterization of the immune microenvironment and MYC\/BCL2 double expression reveal heterogeneity in diffuse large B-cell Lymphoma. Clin Cancer Res. 2022;28:972\u201383.","journal-title":"Clin Cancer Res"},{"key":"1323_CR33","doi-asserted-by":"publisher","first-page":"958","DOI":"10.1038\/modpathol.2013.214","volume":"27","author":"A Tzankov","year":"2014","unstructured":"Tzankov A, Xu-Monette ZY, Gerhard M, Visco C, Dirnhofer S, Gisin N, et al. Rearrangements of MYC gene facilitate risk stratification in diffuse large B-cell lymphoma patients treated with rituximab-CHOP. Mod Pathol. 2014;27:958\u201371.","journal-title":"Mod Pathol"},{"key":"1323_CR34","doi-asserted-by":"publisher","first-page":"3391","DOI":"10.1182\/bloodadvances.2020001949","volume":"4","author":"ZY Xu-Monette","year":"2020","unstructured":"Xu-Monette ZY, Zhang H, Zhu F, Tzankov A, Bhagat G, Visco C, et al. A refined cell-of-origin classifier with targeted NGS and artificial intelligence shows robust predictive value in DLBCL. Blood Adv. 2020;4:3391\u2013404.","journal-title":"Blood Adv"},{"key":"1323_CR35","doi-asserted-by":"publisher","DOI":"10.1038\/s41408-022-00617-5","volume":"12","author":"M Albitar","year":"2022","unstructured":"Albitar M, Zhang H, Goy A, Xu-Monette ZY, Bhagat G, Visco C, et al. Determining clinical course of diffuse large B-cell lymphoma using targeted transcriptome and machine learning algorithms. Blood Cancer J. 2022;12:25.","journal-title":"Blood Cancer J"},{"key":"1323_CR36","doi-asserted-by":"publisher","first-page":"W216","DOI":"10.1093\/nar\/gkac194","volume":"50","author":"BT Sherman","year":"2022","unstructured":"Sherman BT, Hao M, Qiu J, Jiao X, Baseler MW, Lane HC, et al. DAVID: a web server for functional enrichment analysis and functional annotation of gene lists (2021 update). Nucleic Acids Res. 2022;50:W216\u201321.","journal-title":"Nucleic Acids Res"},{"key":"1323_CR37","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1038\/nprot.2008.211","volume":"4","author":"W da Huang","year":"2009","unstructured":"da Huang W, Sherman BT, Lempicki RA. Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat Protoc. 2009;4:44\u201357.","journal-title":"Nat Protoc"},{"key":"1323_CR38","doi-asserted-by":"publisher","first-page":"4164","DOI":"10.1073\/pnas.0308531101","volume":"101","author":"JP Brunet","year":"2004","unstructured":"Brunet JP, Tamayo P, Golub TR, Mesirov JP. Metagenes and molecular pattern discovery using matrix factorization. Proc Natl Acad Sci USA. 2004;101:4164\u20139.","journal-title":"Proc Natl Acad Sci USA"},{"key":"1323_CR39","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1007\/978-1-4939-7493-1_12","volume":"1711","author":"B Chen","year":"2018","unstructured":"Chen B, Khodadoust MS, Liu CL, Newman AM, Alizadeh AA. Profiling tumor infiltrating immune cells with CIBERSORT. Methods Mol Biol. 2018;1711:243\u201359.","journal-title":"Methods Mol Biol"},{"key":"1323_CR40","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1038\/nmeth.3337","volume":"12","author":"AM Newman","year":"2015","unstructured":"Newman AM, Liu CL, Green MR, Gentles AJ, Feng W, Xu Y, et al. Robust enumeration of cell subsets from tissue expression profiles. Nat Methods. 2015;12:453\u20137.","journal-title":"Nat Methods"},{"key":"1323_CR41","doi-asserted-by":"publisher","DOI":"10.1038\/s41408-020-0312-7","volume":"10","author":"H Zhou","year":"2020","unstructured":"Zhou H, Xu-Monette ZY, Xiao L, Strati P, Hagemeister FB, He Y, et al. Prognostic factors, therapeutic approaches, and distinct immunobiologic features in patients with primary mediastinal large B-cell lymphoma on long-term follow-up. Blood Cancer J. 2020;10:49.","journal-title":"Blood Cancer J"},{"key":"1323_CR42","doi-asserted-by":"publisher","DOI":"10.1186\/s13059-014-0550-8","volume":"15","author":"MI Love","year":"2014","unstructured":"Love MI, Huber W, Anders S. Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol. 2014;15:550.","journal-title":"Genome Biol"},{"key":"1323_CR43","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1182\/blood-2003-05-1545","volume":"103","author":"CP Hans","year":"2004","unstructured":"Hans CP, Weisenburger DD, Greiner TC, Gascoyne RD, Delabie J, Ott G, et al. Confirmation of the molecular classification of diffuse large B-cell lymphoma by immunohistochemistry using a tissue microarray. Blood. 2004;103:275\u201382.","journal-title":"Blood"},{"key":"1323_CR44","doi-asserted-by":"publisher","first-page":"eabh2169","DOI":"10.1126\/sciadv.abh2169","volume":"7","author":"M Karlsson","year":"2021","unstructured":"Karlsson M, Zhang C, M\u201aar L, Zhong W, Digre A, Katona B. A single-cell type transcriptomics map of human tissues. Sci Adv. 2021;7:eabh2169","journal-title":"Sci Adv"},{"key":"1323_CR45","first-page":"eaax9198","volume":"366","author":"M Uhlen","year":"2019","unstructured":"Uhlen M, Karlsson MJ, Zhong W, Tebani A, Pou C, Mikes J. A genome-wide transcriptomic analysis of protein-coding genes in human blood cells. Science. A genome-wide transcriptomic analysis of protein-coding genes in human blood cells. Science. 2019;366:eaax9198","journal-title":"A genome-wide transcriptomic analysis of protein-coding genes in human blood cells. Science"},{"key":"1323_CR46","doi-asserted-by":"publisher","first-page":"e0294236","DOI":"10.1371\/journal.pone.0294236","volume":"18","author":"D Tang","year":"2023","unstructured":"Tang D, Chen M, Huang X, Zhang G, Zeng L, Zhang G, et al. SRplot: A free online platform for data visualization and graphing. PLOS ONE. 2023;18:e0294236.","journal-title":"PLOS ONE"},{"key":"1323_CR47","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1002\/path.2399","volume":"216","author":"M Booman","year":"2008","unstructured":"Booman M, Szuhai K, Rosenwald A, Hartmann E, Kluin-Nelemans H, de Jong D, et al. Genomic alterations and gene expression in primary diffuse large B-cell lymphomas of immune-privileged sites: the importance of apoptosis and immunomodulatory pathways. J Pathol. 2008;216:209\u201317.","journal-title":"J Pathol"},{"key":"1323_CR48","doi-asserted-by":"publisher","DOI":"10.1002\/hem3.70024","volume":"8","author":"A Rivas-Delgado","year":"2024","unstructured":"Rivas-Delgado A, L\u00f3pez C, Clot G, Nadeu F, Grau M, Frigola G, et al. Testicular large B-cell lymphoma is genetically similar to PCNSL and distinct from nodal DLBCL. Hemasphere. 2024;8:e70024.","journal-title":"Hemasphere"},{"key":"1323_CR49","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1038\/s41392-023-01358-y","volume":"8","author":"R Shen","year":"2023","unstructured":"Shen R, Fu D, Dong L, Zhang MC, Shi Q, Shi ZY, et al. Simplified algorithm for genetic subtyping in diffuse large B-cell lymphoma. Signal Transduct Target Ther. 2023;8:145.","journal-title":"Signal Transduct Target Ther"},{"key":"1323_CR50","doi-asserted-by":"publisher","first-page":"D1055","DOI":"10.1093\/nar\/gkab733","volume":"50","author":"I Kavakiotis","year":"2022","unstructured":"Kavakiotis I, Alexiou A, Tastsoglou S, Vlachos IS, Hatzigeorgiou AG. DIANA-miTED: a microRNA tissue expression database. Nucleic Acids Res. 2022;50:D1055\u2013D61.","journal-title":"Nucleic Acids Res"},{"key":"1323_CR51","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1002\/path.2033","volume":"210","author":"M Booman","year":"2006","unstructured":"Booman M, Douwes J, Glas AM, de Jong D, Schuuring E, Kluin PM. Primary testicular diffuse large B-cell lymphomas have activated B-cell-like subtype characteristics. J Pathol. 2006;210:163\u201371.","journal-title":"J Pathol"},{"key":"1323_CR52","doi-asserted-by":"publisher","first-page":"1757","DOI":"10.2147\/JIR.S341355","volume":"15","author":"D Guo","year":"2022","unstructured":"Guo D, Hong L, Ji H, Jiang Y, Lu L, Wang X, et al. The mutation of BTG2 gene predicts a poor outcome in primary testicular diffuse large B-cell lymphoma. J Inflamm Res. 2022;15:1757\u201369.","journal-title":"J Inflamm Res"},{"key":"1323_CR53","doi-asserted-by":"publisher","DOI":"10.1186\/s12967-024-05140-8","volume":"22","author":"W Zhang","year":"2024","unstructured":"Zhang W, Yang P, Yang Y, Liu S, Xu Y, Wu C, et al. Genomic landscape and distinct molecular subtypes of primary testicular lymphoma. J Transl Med. 2024;22:414.","journal-title":"J Transl Med"},{"key":"1323_CR54","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1007\/s00432-020-03429-x","volume":"147","author":"G Belge","year":"2021","unstructured":"Belge G, Grobelny F, Radtke A, Bodes J, Matthies C, W\u00fclfing C, et al. Serum levels of microRNA-371a-3p are not elevated in testicular tumours of non-germ cell origin. J Cancer Res Clin Oncol. 2021;147:435\u201343.","journal-title":"J Cancer Res Clin Oncol"},{"key":"1323_CR55","doi-asserted-by":"publisher","first-page":"5369","DOI":"10.1158\/0008-5472.CAN-21-1452","volume":"81","author":"J King","year":"2021","unstructured":"King J, Adra N, Einhorn LH. Testicular cancer: biology to bedside. Cancer Res. 2021;81:5369\u201376.","journal-title":"Cancer Res"},{"key":"1323_CR56","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1016\/j.gendis.2023.02.036","volume":"11","author":"Z Bian","year":"2024","unstructured":"Bian Z, Gu B, Shi G, Guo J, Li D, Zeng H, et al. The single-cell landscape reveals unique tumor subsets and microenvironments associated with poor clinical outcomes in primary testicular diffuse large B-cell lymphoma. Genes Dis. 2024;11:80\u20133.","journal-title":"Genes Dis"},{"key":"1323_CR57","doi-asserted-by":"publisher","first-page":"2304","DOI":"10.18632\/oncotarget.23409","volume":"9","author":"V Arnhold","year":"2018","unstructured":"Arnhold V, Schmelz K, Proba J, Winkler A, Wunschel J, Toedling J, et al. Reactivating TP53 signaling by the novel MDM2 inhibitor DS-3032b as a therapeutic option for high-risk neuroblastoma. Oncotarget. 2018;9:2304\u201319.","journal-title":"Oncotarget"},{"key":"1323_CR58","doi-asserted-by":"publisher","first-page":"2721","DOI":"10.1158\/0008-5472.CAN-17-0949","volume":"78","author":"J Ishizawa","year":"2018","unstructured":"Ishizawa J, Nakamaru K, Seki T, Tazaki K, Kojima K, Chachad D, et al. Predictive gene signatures determine tumor sensitivity to MDM2 inhibition. Cancer Res. 2018;78:2721\u201331.","journal-title":"Cancer Res"},{"key":"1323_CR59","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1158\/1541-7786.MCR-20-0466","volume":"19","author":"M Deng","year":"2021","unstructured":"Deng M, Xu-Monette ZY, Pham LV, Wang X, Tzankov A, Fang X, et al. Aggressive B-cell Lymphoma with MYC\/TP53 dual alterations displays distinct clinicopathobiological features and response to novel targeted agents. Mol Cancer Res. 2021;19:249\u201360.","journal-title":"Mol Cancer Res"},{"key":"1323_CR60","doi-asserted-by":"publisher","first-page":"1705","DOI":"10.1016\/j.ccell.2023.09.004","volume":"41","author":"MC Zhang","year":"2023","unstructured":"Zhang MC, Tian S, Fu D, Wang L, Cheng S, Yi HM, et al. Genetic subtype-guided immunochemotherapy in diffuse large B cell lymphoma: The randomized GUIDANCE-01 trial. Cancer Cell. 2023;41:1705\u201316.e5.","journal-title":"Cancer Cell"}],"container-title":["Blood Cancer Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41408-025-01323-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41408-025-01323-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41408-025-01323-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,7]],"date-time":"2025-09-07T15:26:18Z","timestamp":1757258778000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41408-025-01323-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,17]]},"references-count":60,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["1323"],"URL":"https:\/\/doi.org\/10.1038\/s41408-025-01323-8","relation":{},"ISSN":["2044-5385"],"issn-type":[{"value":"2044-5385","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,17]]},"assertion":[{"value":"24 January 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 May 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 June 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 July 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"123"}}